Granite Point Capital Management, L.P.

Holdings History for Aclaris Therapeutics, Inc. - Common Stock, $0.00001 par value (ACRS)

Symbol: ACRS on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Sep 2017		-1.2%	$0	0	-65,680	-100%	$3.61	Q3 2017
30 Jun 2017	1.2%	0%	$1,781,000	65,680	0		$27.12	Q2 2017
31 Mar 2017	1.3%	-1.3%	$1,959,000	65,680	-65,320	-50%	$29.83	Q1 2017
31 Dec 2016	3.1%	+2.3%	$3,555,000	131,000	+95,000	+264%	$27.14	Q4 2016
30 Sep 2016	0.76%	+0.76%	$922,000	36,000	+36,000	NEW	$25.61	Q3 2016

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.